...
首页> 外文期刊>Toxicology and Applied Pharmacology >Use of genomic data in risk assessment case study: II. Evaluation of the dibutyl phthalate toxicogenomic data set
【24h】

Use of genomic data in risk assessment case study: II. Evaluation of the dibutyl phthalate toxicogenomic data set

机译:基因组数据在风险评估案例研究中的应用:II。邻苯二甲酸二丁酯毒物基因组数据集的评估

获取原文
获取原文并翻译 | 示例
           

摘要

An evaluation of the toxicogenomic data set for dibutyl phthalate (DBP) and male reproductive developmental effects was performed as part of a larger case study to test an approach for incorporating genomic data in risk assessment. The DBP toxicogenomic data set is composed of nine in vivo studies from the published literature that exposed rats to DBP during gestation and evaluated gene expression changes in testes or Wolffian ducts of male fetuses. The exercise focused on qualitative evaluation, based on a lack of available dose-response data, of the DBP toxicogenomic data set to postulate modes and mechanisms of action for the male reproductive developmental outcomes, which occur in the lower dose range. A weight-of-evidence evaluation was performed on the eight DBP toxicogenomic studies of the rat testis at the gene and pathway levels. The results showed relatively strong evidence of DBP-induced downregulation of genes in the steroidogenesis pathway and lipid/sterol/cholesterol transport pathway as well as effects on immediate early gene/growth/differentiation, transcription, peroxisome proliferator-activated receptor signaling and apoptosis pathways in the testis. Since two established modes of action (MOAs), reduced fetal testicular testosterone production and Insl3 gene expression, explain some but not all of the testis effects observed in rats after in utero DBP exposure, other MOAs are likely to be operative. A reanalysis of one DBP microarray study identified additional pathways within cell signaling, metabolism, hormone, disease, and cell adhesion biological processes. These putative new pathways may be associated with DBP effects on the testes that are currently unexplained. This case study on DBP identified data gaps and research needs for the use of toxicogenomic data in risk assessment. Furthermore, this study demonstrated an approach for evaluating toxicogenomic data in human health risk assessment that could be applied to future chemicals.
机译:作为较大案例研究的一部分,对邻苯二甲酸二丁酯(DBP)和男性生殖发育影响的毒物基因组数据集进行了评估,以测试将基因组数据纳入风险评估的方法。 DBP毒物基因组数据集由来自公开文献的九项体内研究组成,这些研究在妊娠期间将大鼠暴露于DBP并评估了男性胎儿的睾丸或沃尔夫管中的基因表达变化。这项工作集中在对DBP毒物基因组数据集(基于缺乏可用的剂量反应数据)的定性评估上,以推定在较低剂量范围内发生的男性生殖发育结果的作用方式和作用机制。在基因和途径水平上对大鼠睾丸的八项DBP毒理基因组研究进行了证据权重评估。结果显示相对有力的证据表明DBP诱导的类固醇生成途径和脂质/固醇/胆固醇转运途径中的基因下调,以及对立即早期基因/生长/分化,转录,过氧化物酶体增殖物激活的受体信号转导和细胞凋亡途径的影响。睾丸。由于两种确立的作用模式(MOA),即胎儿睾丸睾丸激素生成减少和Insl3基因表达,可以解释子宫内DBP暴露后在大鼠中观察到的部分但不是全部睾丸效应,因此其他MOA可能有效。对一项DBP微阵列研究的重新分析确定了细胞信号传导,代谢,激素,疾病和细胞粘附生物学过程中的其他途径。这些可能的新途径可能与DBP对目前无法解释的睾丸的作用有关。本DBP案例研究确定了在风险评估中使用毒理基因组数据的数据差距和研究需求。此外,这项研究展示了一种评估人类健康风险评估中毒理基因组学数据的方法,该方法可应用于未来的化学品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号